Levomilnacipran

Overview

Levomilnacipran is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL99946).

API suppliers (2)

Suppliers of Levomilnacipran evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• PIERRE FABRE MEDICAMENTFrance1 active DMF
• MSN PHARMACHEM PRIVATE LTDIndia

Patent & exclusivity (US)

Per the FDA Orange Book (8 approved US products), the latest listed US patent on Levomilnacipran expires 23 May 2032 and exclusivity 24 Mar 2026. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

cis-(1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide

Canonical SMILES

CCN(CC)C(=O)[C@]1(C[C@H]1CN)C2=CC=CC=C2

InChIKey

GJJFMKBJSRMPLA-DZGCQCFKSA-N